Compare Davita Inc (DVA) vs Union Pacific Corporation (UNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Union Pacific Corporation — how do they compare? Davita Inc trades at $178.33 (market cap $11.38B), while Union Pacific Corporation trades at $293.09 (market cap $173.99B). The key difference: Union Pacific Corporation is far larger — about 15.3× Davita Inc's market cap, and Union Pacific Corporation pays a 1.94% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | UNP | |
|---|---|---|
Market Cap | $11.38B | $173.99B |
Sector | Health | Industrials |
52-Week High | $240.96 | $307.32 |
52-Week Low | $103.87 | $214.91 |
Enterprise Value | $24.10B | $203.04B |
Dividend Yield | — | 1.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
Union Pacific (UNP) trades at $292.24, down 0.3% on the day, with a neutral technical signal. The company reported strong Q2 2026 results, beating EPS and revenue estimates, and raised full-year guidance. Fundamentals remain robust with a net income margin of 28.85% and ROE of 39.7%, though valuation ratios like P/E of 23.71 are elevated. Recent news highlights a 3% dividend increase and ongoing merger developments with Norfolk Southern.
The outlook is positive, driven by service-led growth, pricing power, and efficiency gains. Key opportunities include domestic intermodal expansion and margin improvement. Risks involve high fuel costs, regulatory scrutiny of the merger, and economic sensitivity. Analyst consensus is bullish with a $334.33 price target, suggesting significant upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →
